Corbus Pharmaceuticals Holdings, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2013 | $-366.7K | $-366.7K | — | $6.1K |
| FY2014 | $-2.4M | $-2.4M | $64.4K | $193.1K |
| FY2015 | $-4.6M | $-4.7M | $114.0K | $1.2M |
| FY2016 | $-13.6M | $-13.9M | $353.0K | $3.2M |
| FY2017 | $-27.8M | $-28.5M | $707.4K | $5.7M |
| FY2018 | $-30.1M | $-32.4M | $2.3M | $7.6M |
| FY2019 | $-45.7M | $-48.5M | $2.7M | $12.0M |
| FY2020 | $-99.7M | $-100.2M | $484.5K | $12.5M |
| FY2021 | $-48.2M | $-48.2M | $54.2K | $9.5M |
| FY2022 | $-37.5M | $-37.6M | $13.4K | $5.7M |
| FY2023 | $-36.1M | $-36.1M | $0 | $3.5M |
| FY2024 | $-41.8M | $-41.8M | $0 | $6.1M |
| FY2025 | $-64.5M | $-64.5M | $7.0K | $6.3M |